Evidence map›Paper›PMID 26443638›Full record

ArticleDevelopment (Cambridge, England)2015

Prdm12 specifies V1 interneurons through cross-repressive interactions with Dbx1 and Nkx6 genes in Xenopus.

Aurore Thélie, Simon Desiderio, Julie Hanotel, Ian Quigley, Benoit Van Driessche, Anthony Rodari, Mark D Borromeo, Sadia Kricha, François Lahaye, Jenifer Croce and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. PRDM12 in Health and Diseases.International journal of molecular sciences · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Genomics Methods forCold Spring Harbor protocols · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 11 institutions in 5 countries.

Aurore ThélieLaboratory of Developmental Genetics, Université Libre de Bruxelles (ULB), Institute of Molecular Biology and Medecine (IBMM) and ULB Neuroscience Institute, Gosselies B-6041, Belgium.
Simon DesiderioLaboratory of Developmental Genetics, Université Libre de Bruxelles (ULB), Institute of Molecular Biology and Medecine (IBMM) and ULB Neuroscience Institute, Gosselies B-6041, Belgium.
Julie HanotelLaboratory of Developmental Genetics, Université Libre de Bruxelles (ULB), Institute of Molecular Biology and Medecine (IBMM) and ULB Neuroscience Institute, Gosselies B-6041, Belgium.
Ian QuigleyMolecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Benoit Van DriesscheLaboratory of Molecular Virology, ULB, IBMM, Gosselies B-6041, Belgium.
Anthony RodariLaboratory of Molecular Virology, ULB, IBMM, Gosselies B-6041, Belgium.
Mark D BorromeoDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Sadia KrichaLaboratory of Developmental Genetics, Université Libre de Bruxelles (ULB), Institute of Molecular Biology and Medecine (IBMM) and ULB Neuroscience Institute, Gosselies B-6041, Belgium.
François LahayeSorbonne Universités, UPMC Université Paris 06, CNRS UMR 7009, Laboratoire de Biologie du Développement de Villefranche-sur-Mer (UMR 7009), Observatoire Océanologique de Villefranche-sur-Mer, Villefranche-sur-Mer 06230, France.
Jenifer CroceSorbonne Universités, UPMC Université Paris 06, CNRS UMR 7009, Laboratoire de Biologie du Développement de Villefranche-sur-Mer (UMR 7009), Observatoire Océanologique de Villefranche-sur-Mer, Villefranche-sur-Mer 06230, France.
Gustavo Cerda-MoyaDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK.
Jesús Ordoño FernandezLaboratory of Developmental Genetics, Université Libre de Bruxelles (ULB), Institute of Molecular Biology and Medecine (IBMM) and ULB Neuroscience Institute, Gosselies B-6041, Belgium.
Barbara BolleLaboratory of Developmental Genetics, Université Libre de Bruxelles (ULB), Institute of Molecular Biology and Medecine (IBMM) and ULB Neuroscience Institute, Gosselies B-6041, Belgium.
Katharine E LewisDepartment of Biology, Syracuse University, 107 College Place, Syracuse, NY 13244, USA.
Maike SanderDepartments of Pediatrics and Cellular and Molecular Medicine, Pediatric Diabetes Research Center, University of California, San Diego, La Jolla, CA 92093-0695, USA.
Alessandra PieraniGénétique et développement du cortex cerebral, Institut Jacques Monod, CNRS UMR 7592, Université Paris Diderot, Sorbonne Paris Cité, Paris Cedex 13 75205, France.
Michael SchubertSorbonne Universités, UPMC Université Paris 06, CNRS UMR 7009, Laboratoire de Biologie du Développement de Villefranche-sur-Mer (UMR 7009), Observatoire Océanologique de Villefranche-sur-Mer, Villefranche-sur-Mer 06230, France.
Jane E JohnsonDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Christopher R KintnerMolecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Tomas PielerDepartment of Developmental Biochemistry, Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), University of Göttingen, 37077 Göttingen, Germany.
Carine Van LintLaboratory of Molecular Virology, ULB, IBMM, Gosselies B-6041, Belgium.
Kristine A HenningfeldDepartment of Developmental Biochemistry, Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), University of Göttingen, 37077 Göttingen, Germany.
Eric J BellefroidLaboratory of Developmental Genetics, Université Libre de Bruxelles (ULB), Institute of Molecular Biology and Medecine (IBMM) and ULB Neuroscience Institute, Gosselies B-6041, Belgium ebellefr@ulb.ac.be cvcampen@ulb.ac.be.
Claude Van CampenhoutLaboratory of Developmental Genetics, Université Libre de Bruxelles (ULB), Institute of Molecular Biology and Medecine (IBMM) and ULB Neuroscience Institute, Gosselies B-6041, Belgium ebellefr@ulb.ac.be cvcampen@ulb.ac.be.
Université Libre de Bruxelles · BECentre National de la Recherche Scientifique · FRSalk Institute for Biological Studies · USNanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103 · DESorbonne Université · FRSouthwestern Medical CenterSouthwestern Medical Center · USSyracuse University · USUniversity of California San Diego · USUniversity of Cambridge · GBUniversity of Göttingen · DE

Funding

Identifying transcription factors expressed by ventral spinal cord interneuronsR21NS073979 · NINDS · SYRACUSE UNIVERSITY · PI LEWIS, KATHARINE EMMA · 2011 to 2013
$454k
Medical Research Council G0600877Medical Research Council G0801283NINDS NIH HHS R21 NS073979
6 · The paper itself

Abstract

V1 interneurons are inhibitory neurons that play an essential role in vertebrate locomotion. The molecular mechanisms underlying their genesis remain, however, largely undefined. Here, we show that the transcription factor Prdm12 is selectively expressed in p1 progenitors of the hindbrain and spinal cord in the frog embryo, and that a similar restricted expression profile is observed in the nerve cord of other vertebrates as well as of the cephalochordate amphioxus. Using frog, chick and mice, we analyzed the regulation of Prdm12 and found that its expression in the caudal neural tube is dependent on retinoic acid and Pax6, and that it is restricted to p1 progenitors, due to the repressive action of Dbx1 and Nkx6-1/2 expressed in the adjacent p0 and p2 domains. Functional studies in the frog, including genome-wide identification of its targets by RNA-seq and ChIP-Seq, reveal that vertebrate Prdm12 proteins act as a general determinant of V1 cell fate, at least in part, by directly repressing Dbx1 and Nkx6 genes. This probably occurs by recruiting the methyltransferase G9a, an activity that is not displayed by the amphioxus Prdm12 protein. Together, these findings indicate that Prdm12 promotes V1 interneurons through cross-repressive interactions with Dbx1 and Nkx6 genes, and suggest that this function might have only been acquired after the split of the vertebrate and cephalochordate lineages.

Indexed as

AnimalsBase SequenceCarrier ProteinsChick EmbryoChromatin ImmunoprecipitationComputational BiologyDNA, ComplementaryDNA PrimersGene Expression Regulation, DevelopmentalHomeodomain ProteinsImmunohistochemistryIn Situ HybridizationMiceMolecular Sequence DataMorphogenesisNerve Tissue ProteinsCarrier ProteinsDNA, ComplementaryDNA PrimersHomeodomain ProteinsNerve Tissue ProteinsPRDM12 protein, Xenopus laevisInterneuronNeurogenesisPrdmSpinal cordTranscription factor

Identifiers

PMID26443638
PMCPMC4631751
OpenAlexW2211556820

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.